NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$3.83
+0.08 (+2.13%)
As of Mar 25, 4:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.75M
Net Income
-13,462,696
Gross Margin
34.7%
Profit Margin
-490.0%
Rev Growth
+14.6%
D/E Ratio
0.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.7% 34.7% 54.8% 54.8%
Operating Margin -497.9% -448.1% 14.3% 15.1%
Profit Margin -490.0% -465.5% 12.0% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.75M 2.40M 21.69M 16.36M
Gross Profit 954.6K 833.1K 11.89M 8.96M
Operating Income -13,681,819 -10,746,759 3.11M 2.47M
Net Income -13,462,696 -10,574,643 2.61M 1.89M
Gross Margin 34.7% 34.7% 54.8% 54.8%
Operating Margin -497.9% -448.1% 14.3% 15.1%
Profit Margin -490.0% -465.5% 12.0% 11.5%
Rev Growth +14.6% +14.6% +19.5% +23.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 677.7K 677.7K 24.66M 23.39M
Total Equity 23.37M 23.37M 37.36M 36.10M
D/E Ratio 0.03 0.03 0.66 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,315,563 -11,040,133 4.63M 3.66M
Free Cash Flow 2.95M 1.96M